2017 | 2016 | 2015 | 2014
DateTitle 
03/03/17INC Research Appoints William E. Klitgaard and Linda S. Harty to Board of Directors
Klitgaard and Harty bring extensive IT and finance experience to guide the Company’s growth RALEIGH, N.C., March 03, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, today announced the appointment of William E. Klitgaard and Linda S. Harty to the Company’s Board of Directors effective immediately. Mr. Klitgaard previously was President of Enlighten Health, a division of LabCorp, a world healthcare diagnostics c... 
Printer Friendly Version
02/28/17INC Research Reports Fourth Quarter and Full Year 2016 Results
Highlights  Book-to-bill ratio of 1.1x and 1.2x for the fourth quarter and full year 2016, respectively. Net new business awards of $289.6 million and $1.22 billion for the fourth quarter and full year 2016, respectively. Net service revenue of $263.0 million for the fourth quarter, representing growth of 9.0%, and $1,030.3 million for the full year 2016, representing growth of 12.6%. GAAP diluted earnings per share of $0.68 and $2.03 for the fourth quarter and full yea... 
Printer Friendly Version
02/22/17INC Research Expands Functional Service Provider Services Through New Investigator Payment Offering
New service leverages Company’s extensive expertise in investigator payment processing, innovative cloud payment technology through Medidata and builds on extensive FSP capabilities RALEIGH, N.C., Feb. 22, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, today announced expansion of its Functional Service Provider (FSP) service offering to include investigator payment processing, leveraging  the Company’s extens... 
Printer Friendly Version
02/08/17INC Research Further Strengthens Board of Directors Through Appointment of Pharmaceutical Executive Eric P. Pâques
RALEIGH, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, today announced the appointment of Eric Paul Pâques, previously the Chief Executive Officer for GRÜNENTHAL GROUP, to the Company’s Board of Directors.  Mr. Pâques joins the INC Research Board as an independent director and will be a Class I director serving a term ending at the Company’s 2018 Annual Meeting. “We are pleased to welcome Eri... 
Printer Friendly Version
02/06/17INC Research Schedules Fourth Quarter and Year End 2016 Earnings Call for Tuesday, February 28, 2017
RALEIGH, N.C., Feb. 06, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, will release its fourth quarter and full year 2016 financial results on Tuesday, February 28, 2017, prior to its quarterly earnings call at 8:00 a.m. EST. Participants may access the conference call live via webcast on the Investor Relations section of the INC Research website at investor.incresearch.com. To participate via telephone, pl... 
Printer Friendly Version